Brief: Skye Bioscience Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Business Update
20/03/2025 20:49
March 20 (Reuters) - Skye Bioscience Inc SKYE.O: SKYE BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE SKYE BIOSCIENCE INC: CASH RUNWAY PROJECTED THROUGH AT LEAST Q1 2027 Source text: ID:nGNX5DjBcl Further company coverage: SKYE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skye Bioscience
See all newsRCS - Redx Pharma Limited - Redx to Present Poster on RXC008 at UEG Week
RCS - Redx Pharma Limited - Redx Announces ROCKETEER Phase 2 Trial for RXC008
Brief: Skye Bioscience Says John Sharp Resigns As CFO - SEC Filing
Brief: Skye Bioscience - Enters $22 Million Securities Purchase Agreement With Redmile Biopharma Investments Iii - SEC Filing
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM